Skip to content

Author

Y. Vassetzky

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Multiple Sclerosis and Viruses: « Liaisons Dangereuses »

ABSTRACT Multiple sclerosis (MS) is a complex, multifactorial neurodegenerative disease with an aetiology that is still partially elusive. Several risk factors are associated with MS development including genetic predisposition and various environmental stressors; however, recently, viral infections have gained signifi...

Samanta Plavina, Daniela Malakovska, Jolanta Kalnina et al. · 0 citations
Open access Sep 2026

5-((5-Nitrofuran-2-yl)allylidene)-2-thioxo-4-thiazolidinones Target Microtubules in Breast Cancer Cells

4-Thiazolidinone derivatives, a group of compounds with a broad spectrum of activity and anticancer properties, are used in medicine as anti-inflammatory, antiviral, antibacterial, antidiabetic, and blood pressure-lowering drugs; some of them are now in phase II and III clinical trials as anticancer drugs. Here, we eva...

Magdalena Podolak, Rostyslav Dudchak, Agnieszka Gornowicz et al. · 0 citations
Review Open access Sep 2026

Metal-Based Epigenetic Therapeutics in Cancer: Mechanisms, Targets, and Opportunities for Overcoming Drug Resistance.

The growing potential of metal-based epigenetic therapies to overcome therapeutic resistance through multimodal mechanisms that combine epigenetic reprogramming with modulation of DNA damage responses, oxidative stress, protein homeostasis, and chromatin organization is highlighted.

Julia Astapczuk, O. Szewczyk-Roszczenko, Y. Vassetzky et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.